Peal Capital

PEAL Capital Partners is a female-founded, European based, lower midcap private equity firm specializing in control investments within the rapidly growing sector of Longevity and Hormones (“L&H”). The senior team have worked together since 2006 and built up a strong track record across multiple economic cycles and regions. Leveraging our extensive family office network and Medical Panel, PEAL researches and sources companies in the areas of male and female hormones, blood testing and pharmacy to support longevity-focused training and clinical services. We find that this methodology creates sustainable business models with attractive rewards for the portfolio companies and the investors.